3M's transdermal microneedles to be used for VaxInnate's flu vaccine
This article was originally published in Scrip
Executive Summary
The private US company VaxInnate has non-exclusively licensed 3M Drug Delivery System's microneedle technology to deliver its M2e universal flu vaccine via a transdermal patch.